153 related articles for article (PubMed ID: 8141084)
1. Intracranial hemorrhage risk and new thrombolytic therapies in acute myocardial infarction.
Hillegass WB; Jollis JG; Granger CB; Ohman EM; Califf RM; Mark DB
Am J Cardiol; 1994 Mar; 73(7):444-9. PubMed ID: 8141084
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction.
Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L
N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117
[TBL] [Abstract][Full Text] [Related]
3. Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis.
Hiatt MD
Cardiology; 1999; 91(4):243-9. PubMed ID: 10545680
[TBL] [Abstract][Full Text] [Related]
4. [Intracranial hemorrhage following thrombolytic therapy in acute myocardial infarct].
Torres Martínez G; Rodríguez García P; Cantón Martínez A; Castillo Soria F; Galcerá Tomás J; García Paredes T; Bru Cartagena M; Jara Pérez P
Rev Esp Cardiol; 1994 Feb; 47(2):73-80. PubMed ID: 8165351
[TBL] [Abstract][Full Text] [Related]
5. Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
Aylward PE; Wilcox RG; Horgan JH; White HD; Granger CB; Califf RM; Topol EJ
Ann Intern Med; 1996 Dec; 125(11):891-900. PubMed ID: 8967669
[TBL] [Abstract][Full Text] [Related]
6. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.
Sloan MA; Sila CA; Mahaffey KW; Granger CB; Longstreth WT; Koudstaal P; White HD; Gore JM; Simoons ML; Weaver WD; Green CL; Topol EJ; Califf RM
Circulation; 1998 Oct; 98(14):1376-82. PubMed ID: 9760291
[TBL] [Abstract][Full Text] [Related]
7. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
GUSTO investigators
N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
[TBL] [Abstract][Full Text] [Related]
8. Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors.
De Jaegere PP; Arnold AA; Balk AH; Simoons ML
J Am Coll Cardiol; 1992 Feb; 19(2):289-94. PubMed ID: 1732354
[TBL] [Abstract][Full Text] [Related]
9. Thrombolytic therapy guided by a decision analysis model: are there potential benefits for patient management?
Kellett J; Ryan B
Clin Cardiol; 1998 Feb; 21(2):93-8. PubMed ID: 9491947
[TBL] [Abstract][Full Text] [Related]
10. Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis.
Sloan MA; Gore JM
Am J Cardiol; 1992 Jan; 69(2):21A-38A. PubMed ID: 1729876
[TBL] [Abstract][Full Text] [Related]
11. Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project.
Brass LM; Lichtman JH; Wang Y; Gurwitz JH; Radford MJ; Krumholz HM
Stroke; 2000 Aug; 31(8):1802-11. PubMed ID: 10926938
[TBL] [Abstract][Full Text] [Related]
12. Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.
Mahaffey KW; Granger CB; Sloan MA; Green CL; Gore JM; Weaver WD; White HD; Simoons ML; Barbash GI; Topol EJ; Califf RM
Am Heart J; 1999 Sep; 138(3 Pt 1):493-9. PubMed ID: 10467200
[TBL] [Abstract][Full Text] [Related]
13. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico II (GISSI-2), and The International Study Group.
Maggioni AP; Franzosi MG; Santoro E; White H; Van de Werf F; Tognoni G
N Engl J Med; 1992 Jul; 327(1):1-6. PubMed ID: 1598096
[TBL] [Abstract][Full Text] [Related]
14. Intracranial hemorrhage after thrombolytic therapy. A perspective.
Simoons ML; de Jaegere P; van Domburg R; Boersma E
Z Kardiol; 1993; 82 Suppl 2():153-6. PubMed ID: 8328195
[TBL] [Abstract][Full Text] [Related]
15. [Intracranial hemorrhage following second thrombolytic treatment of myocardial reinfarction].
Valentín Segura V; Valls Grima F; Broch Porcar MJ; Miralles Serrano L; Olivares Toledo D; Alvarez Cebrián F
Rev Esp Cardiol; 1994 Dec; 47(12):836-8. PubMed ID: 7855379
[TBL] [Abstract][Full Text] [Related]
16. Risk-benefit of thrombolysis.
Simoons ML
Cardiol Clin; 1995 Aug; 13(3):339-45. PubMed ID: 7585771
[TBL] [Abstract][Full Text] [Related]
17. CT patterns of intracranial hemorrhage complicating thrombolytic therapy for acute myocardial infarction.
Uglietta JP; O'Connor CM; Boyko OB; Aldrich H; Massey EW; Heinz ER
Radiology; 1991 Nov; 181(2):555-9. PubMed ID: 1924804
[TBL] [Abstract][Full Text] [Related]
18. Thrombolytic therapy for evolving myocardial infarction needs an approach that integrates benefit and risk.
Arnold AE; Simoons ML
Eur Heart J; 1995 Nov; 16(11):1502-9. PubMed ID: 8881841
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
20. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.
Gurwitz JH; Gore JM; Goldberg RJ; Barron HV; Breen T; Rundle AC; Sloan MA; French W; Rogers WJ
Ann Intern Med; 1998 Oct; 129(8):597-604. PubMed ID: 9786806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
